JP2004504802A5 - - Google Patents

Download PDF

Info

Publication number
JP2004504802A5
JP2004504802A5 JP2001520922A JP2001520922A JP2004504802A5 JP 2004504802 A5 JP2004504802 A5 JP 2004504802A5 JP 2001520922 A JP2001520922 A JP 2001520922A JP 2001520922 A JP2001520922 A JP 2001520922A JP 2004504802 A5 JP2004504802 A5 JP 2004504802A5
Authority
JP
Japan
Prior art keywords
activity
pharmaceutical composition
modulator
therapeutic agent
composition according
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2001520922A
Other languages
English (en)
Japanese (ja)
Other versions
JP2004504802A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2000/023844 external-priority patent/WO2001016377A2/en
Publication of JP2004504802A publication Critical patent/JP2004504802A/ja
Publication of JP2004504802A5 publication Critical patent/JP2004504802A5/ja
Pending legal-status Critical Current

Links

JP2001520922A 1999-08-30 2000-08-30 骨粗鬆症の診断および療法 Pending JP2004504802A (ja)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US15146099P 1999-08-30 1999-08-30
PCT/US2000/023844 WO2001016377A2 (en) 1999-08-30 2000-08-30 Diagnostics and therapeutics for osteoporosis

Publications (2)

Publication Number Publication Date
JP2004504802A JP2004504802A (ja) 2004-02-19
JP2004504802A5 true JP2004504802A5 (https=) 2007-04-12

Family

ID=22538869

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2001520922A Pending JP2004504802A (ja) 1999-08-30 2000-08-30 骨粗鬆症の診断および療法

Country Status (11)

Country Link
US (2) US6558905B1 (https=)
EP (1) EP1212464B1 (https=)
JP (1) JP2004504802A (https=)
AT (1) ATE318328T1 (https=)
AU (2) AU785040B2 (https=)
BR (1) BR0014150A (https=)
CA (1) CA2382848C (https=)
DE (1) DE60026150T2 (https=)
ES (1) ES2261239T3 (https=)
MX (1) MXPA02002251A (https=)
WO (1) WO2001016377A2 (https=)

Families Citing this family (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IL147182A0 (en) * 1999-06-30 2002-08-14 Interleukin Genetics Inc Diagnostics and therapeutics for diseases associated with an il-1 inflammatory haplorype
US20090023147A1 (en) * 1999-08-30 2009-01-22 Kenneth Kornman Diagnostics and therapeutics for osteoporosis
AU2002320100A1 (en) * 2001-06-15 2003-01-02 Interleukin Genetics, Inc. Methods for detecting and treating the early onset of aging-related conditions
US20070264645A1 (en) * 2002-01-25 2007-11-15 Kenneth Kornman IL-1 gene cluster and associated inflammatory polymorphisms and haplotypes
CA2473641A1 (en) * 2002-01-25 2003-08-07 Interleukin Genetics, Inc. The il-1 gene cluster and associated inflammatory polymorphisms and haplotypes
AU2003265676A1 (en) * 2002-08-24 2004-03-11 Creighton University Methods for detecting genes associated with bone properties and/or height
CA2512549A1 (en) * 2003-01-16 2004-08-05 Decode Genetics Ehf. Methods for diagnosing osteoporosis or a susceptibility to osteoporosis based on haplotype association
DE602004030367D1 (de) 2003-08-08 2011-01-13 Interleukin Genetics Inc Diagnostikum für osteoporose
US7309589B2 (en) 2004-08-20 2007-12-18 Vironix Llc Sensitive detection of bacteria by improved nested polymerase chain reaction targeting the 16S ribosomal RNA gene and identification of bacterial species by amplicon sequencing
RU2271827C1 (ru) * 2004-09-28 2006-03-20 Федеральное государственное учреждение"Санкт-Петербургский научно-исследовательский институт уха, горла, носа и речи Федерального агенства по здравоохранению и социальному развитию"(ФГУ "СПбНИИ ЛОР Росздрава") Способ определения тактики лечения рекомбинантным цитокином, регулирующим воспаление
US7353662B2 (en) * 2004-12-22 2008-04-08 York International Corporation Medium voltage starter for a chiller unit
US8590329B2 (en) 2004-12-22 2013-11-26 Johnson Controls Technology Company Medium voltage power controller
US8105775B2 (en) * 2005-10-25 2012-01-31 Interleukin Genetics, Inc. IL-1 gene cluster and associated inflammatory polymorphisms and haplotypes
US8101360B2 (en) * 2006-11-15 2012-01-24 Interleukin Genetics, Inc. IL-1 gene cluster, insulin resistance and coronary artery disease associated polymorphisms and haplotypes and methods of using same
CA3011363A1 (en) 2016-01-12 2017-07-20 Interleukin Genetics, Inc. Methods for predicting response to treatment
US10329620B2 (en) 2017-01-12 2019-06-25 Cardioforecast Ltd. Methods and kits for treating cardiovascular disease
US20220249660A1 (en) 2019-06-06 2022-08-11 Sitokine Limited Compositions and methods for treating lung, colorectal and breast cancer
WO2021028469A1 (en) 2019-08-12 2021-02-18 Sitokine Limited Compositions and methods for treating cytokine release syndrome and neurotoxicity
WO2021205013A1 (en) 2020-04-09 2021-10-14 Sitokine Limited Compositions and methods for treating covid-19

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB8311018D0 (en) 1983-04-22 1983-05-25 Amersham Int Plc Detecting mutations in dna
CA1316520C (en) 1987-05-19 1993-04-20 Larry C. Hamilton Valve
FR2650840B1 (fr) 1989-08-11 1991-11-29 Bertin & Cie Procede rapide de detection et/ou d'identification d'une seule base sur une sequence d'acide nucleique, et ses applications
WO1993011149A1 (en) 1991-12-03 1993-06-10 Thomas Jefferson University Methods of detecting a genetic predisposition for osteoporosis
CA2141300C (en) 1992-07-31 2006-03-14 Nigel Alexander Morrison Assessment of vitamin d receptors allelic variation
ATE277946T1 (de) 1992-12-28 2004-10-15 David J Baylink Methode zur messung der knochenresorption
IL108947A0 (en) 1993-03-12 1994-06-24 Osteopharm Ltd Bone stimulating factor
CA2164498C (en) 1993-07-09 2007-09-11 Paul A. Price Assay for ykl-40 as a marker for degradation of mammalian connective tissue matrices
US5698399A (en) * 1996-04-05 1997-12-16 Duff; Gordon W. Detecting genetic predisposition for osteoporosis
GB9706359D0 (en) * 1997-03-27 1997-05-14 Gemini International Holdings Polymorphisms of an il-1 receptor antagonist gene
GB9711040D0 (en) * 1997-05-29 1997-07-23 Duff Gordon W Prediction of inflammatory disease

Similar Documents

Publication Publication Date Title
JP2004504802A5 (https=)
CA2382848A1 (en) Diagnostics and therapeutics for osteoporosis
JP2003508022A5 (https=)
JP2002533096A5 (https=)
KR101953176B1 (ko) 미처리 혈액을 사용한 pcr 및 hla 타이핑 방법
EP1375672A1 (en) Method of detecting nucleic acid relating to disease
CA2435917A1 (en) Highly sensitive method for the detection of cytosine methylation patterns
JP2003530860A (ja) 新生又は非新生細胞の検出方法
JP2014530819A5 (https=)
KR102050637B1 (ko) 약물 부작용과 관련된 대립유전자 및 이의 검출 방법
RU2009147281A (ru) Способы и композиции для диагностики и лечения волчанки
JP5837825B2 (ja) 線維症感受性遺伝子及びその使用
EP2423324A1 (en) Probe set for identification of nucleotide mutation, and method for identification of nucleotide mutation
JP2003516162A (ja) 核酸分析に基づく薬物スクリーニングのための装置および方法
EP1054066A2 (en) Method for anticipating sensitivity to medicine for osteoporosis and a reagent therefor
Koh et al. Oestrogen receptor α genotype, and interactions between vitamin D receptor and transforming growth factor‐β1 genotypes are associated with quantitative calcaneal ultrasound in postmenopausal women
Wang et al. Characteristics of Dystrophin Gene Mutations Among Chinese Patients as Revealed by Multiplex Ligation–Dependent Probe Amplification
CN100362110C (zh) 瘦素和瘦素受体基因多态性检测芯片及其制备方法和用途
EP1436756B1 (en) Polymorphic marker that can be used to assess the efficacy of interferon therapy
RU2005127807A (ru) Применение нового полиморфизма в гене hsgki для диагностики гипертонии и применение генов семейства sgk для диагностики и терапии синдрома удлиненного q/t-периода
US20180371542A1 (en) Opioid receptor blockade in treating alcohol use disorders
DE69833104D1 (de) Glaukom diagnose und behandlung
US20030219775A1 (en) Nucleic acid diagnostic reagents and methods for detecting nucleic acids, polynucleotides and oligonucleotides
JP2001286288A (ja) 診断法
JP2001333798A (ja) ビタミンd受容体遺伝子、アポリポタンパクe遺伝子およびエストロゲン受容体遺伝子の遺伝子多型同時検出用試薬および該遺伝子多型同時検出方法